Key result
Recurrent weekly exposure to moderate doses of subclinical lipopolysaccharide in mice significantly increased left ventricular collagen fraction area to 9.7% compared to 3.0% with saline, and increased mortality.
Why the study?
Does recurrent exposure to subclinical lipopolysaccharide increase mortality and induce cardiac fibrosis in mice?
Does recurrent exposure to subclinical lipopolysaccharide increase mortality and induce cardiac fibrosis in mice?
Recurrent exposure to subclinical lipopolysaccharide in mice increases mortality and induces dose-dependent cardiac fibrosis without altering left ventricular systolic function.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for endotoxin-driven fibrosis in mice; human relevance and mechanisms require prospective study.
BACKGROUND: Circulating subclinical lipopolysaccharide (LPS) occurs in health and disease. Ingesting high fatty meals increases LPS that cause metabolic endotoxemia. Subclinical LPS in periodontal disease may impair endothelial function. The heart may be targeted as cardiac cells express TLR4, the LPS receptor. It was hypothesized that recurrent exposure to subclinical LPS increases mortality and causes cardiac fibrosis. METHODS: C57Bl/6 mice were injected with intraperitoneal saline (control), low dose LPS (0.1 or 1 mg/kg), or moderate dose LPS (10 or 20 mg/kg), once a week for 3 months. Left ventricular (LV) function (echocardiography), hemodynamics (tail cuff pressure) and electrocardiograms (telemetry) were measured. Cardiac fibrosis was assessed by picrosirius red staining and LV expression of fibrosis related genes (QRT-PCR). Adult cardiac fibroblasts were isolated and exposed to LPS. RESULTS: LPS injections transiently increased heart rate and blood pressure (<6 hours) and mildly decreased LV function with full recovery by 24 hours. Mice tolerated weekly LPS for 2-3 months with no change in activity, appearance, appetite, weight, blood pressure, LV function, oximetry, or blood chemistries. Mortality increased after 60-90 days with moderate, but not low dose LPS. Arrhythmias occurred a few hours before death. LV collagen fraction area increased dose-dependently from 3.0±0.5% (SEM) in the saline control group, to 5.6±0.5% with low dose LPS and 9.7±0.9% with moderate dose LPS (P<0.05 moderate vs low dose LPS, and each LPS dose vs control). LPS increased LV expression of collagen Iα1, collagen IIIα1, MMP2, MMP9, TIMP1, periostin and IL-6 (P<0.05 moderate vs low dose LPS and vs control). LPS increased α-SMA immunostaining of myofibroblasts. LPS dose-dependently increased IL-6 in isolated adult cardiac fibroblasts. CONCLUSIONS: Recurrent exposure to subclinical LPS increases mortality and induces cardiac fibrosis.
No takes yet. Share an insight, caveat, or question.
Lew et al. (2013) studied Healthy (exposed to subclinical lipopolysaccharide). Lipopolysaccharide (LPS) vs. Saline was evaluated on Left ventricular collagen fraction area (p=<0.05). Recurrent weekly exposure to moderate doses of subclinical lipopolysaccharide in mice significantly increased left ventricular collagen fraction area to 9.7% compared to 3.0% with saline, and increased mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: